A new review in Medical Oncology details how liquid biomarkers, advanced imaging, and artificial intelligence are transforming pre-biopsy discrimination of prostate cancer from benign disease.

Add Yahoo as a preferred source to see more of our stories on Google. PSA stands for prostate-specific antigen, a substance naturally produced in prostate tissue. A small amount of PSA regularly ...

Prostate cancer screening generally begins around age 50, while men at higher risk may consider starting earlier, closer to 40 or 45.

Add Yahoo as a preferred source to see more of our stories on Google. b' Prostate cancer is the most common form of cancer among men in England, with cases surging by 25 per cent between 2019 and 2023 ...

Prostate cancer screening compares favorably to screening for breast cancer in identifying significant cancers, reducing mortality and avoiding unnecessary harms, says new research. The findings are ...

Prostate cancer is common. About 200 in every 1,000 Australian men will be told they have prostate cancer by the age of 85. But the chance of dying from it is much lower: around 18 in 1,000 cases.

Prostate cancer is the second leading cause of cancer deaths among men in the U.S. with more than 35,000 dying in 2025. It’s ...

Opinion: One in 44 men will die of prostate cancer. This is unfortunate because it is among the most treatable cancers when ...

The Prostate Cancer Foundation welcomes the National Party’s commitment to establish a prostate cancer screening pilot as an important step towards detecting the disease earlier and saving more lives.

More men in the Busoga Sub-region are turning up for prostate cancer screening, a development health workers say signals a shift in attitudes towards a disease that has traditionally been associated ...

PSA levels can be elevated for reasons other than cancer, such as an enlarged or inflamed prostate. False positive and false negative PSA test results are possible. The American Cancer Society does ...